Evaluating the Prognostic Significance of Immunoscore in Liver Metastases from Colorectal Cancer: A Meta-Analysis Demonstrates the Advantages of Profiling Metastatic Tumors Over Primary Tumors - Takeaways - MDSpire

Evaluating the Prognostic Significance of Immunoscore in Liver Metastases from Colorectal Cancer: A Meta-Analysis Demonstrates the Advantages of Profiling Metastatic Tumors Over Primary Tumors

  • By

  • Sen Hou

  • Xinchun Wu

  • Haodong Zhu

  • Yuchen Yao

  • Zhidong Gao

  • Yingjiang Ye

  • Kai Shen

  • March 14, 2026

  • 0 min

Share

  • 1

    Colorectal cancer is the third most diagnosed and fourth most lethal cancer globally, with liver metastases significantly impacting survival rates.

  • 2

    The Immunoscore (IS) is a promising biomarker that quantifies immune cell densities in tumors, showing potential for improved prognosis in colorectal liver metastases.

  • 3

    Current prognostic models like the clinical risk score (CRS) do not fully account for survival differences among colorectal liver metastasis patients.

  • 4

    Studies indicate that the IS of liver metastases may better predict prognosis than the IS of primary tumors in colorectal cancer patients.

  • 5

    This meta-analysis aims to validate the prognostic value of IS in colorectal liver metastases and assess its correlation with clinicopathological parameters.

Original Source(s)

Evaluating the Prognostic Significance of Immunoscore in Liver Metastases from Colorectal Cancer: A Meta-Analysis Demonstrates the Advantages of Profiling Metastatic Tumors Over Primary Tumors

  • by Sen Hou, Xinchun Wu, Haodong Zhu, Yuchen Yao, Zhidong Gao, Yingjiang Ye, Kai Shen

  • March 14, 2026

Related Content

The predictive value of prognostic immune and nutritional index in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy: a retrospective propensity score matching study

Clinical relevance of the identification of the distal end of the palisade vessel in cases with columnar-lined esophagus: a comment on the study by Hatta et al.

Successful reversal of hepatic visceral crisis in HER2-positive metastatic breast cancer: a case report